Literature DB >> 21861459

Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus.

Yoshitha A Wanniarachchi1, Piotr Kaczmarek, Andrea Wan, Elizabeth M Nolan.   

Abstract

Human α-defensin 5 (HD5, HD5(ox) to specify the oxidized and disulfide linked form) is a 32-residue cysteine-rich host-defense peptide, expressed and released by small intestinal Paneth cells, that exhibits antibacterial activity against a number of Gram-negative and -positive bacterial strains. To ascertain the contributions of its disulfide array to structure, antimicrobial activity, and proteolytic stability, a series of HD5 double mutant peptides where pairs of cysteine residues corresponding to native disulfide linkages (Cys(3)-Cys(31), Cys(5)-Cys(20), Cys(10)-Cys(30)) were mutated to Ser or Ala residues, overexpressed in E. coli, purified, and characterized. A hexa mutant peptide, HD5[Ser(hexa)], where all six native Cys residues are replaced by Ser residues, was also evaluated. Removal of a single native S-S linkage influences oxidative folding and regioisomerization, antibacterial activity, Gram-negative bacterial membrane permeabilization, and proteolytic stability. Whereas the majority of the HD5 mutant peptides show low micromolar activity against Gram-negative E. coli ATCC 25922 in colony counting assays, the wild-type disulfide array is essential for low micromolar activity against Gram-positive S. aureus ATCC 25923. Removal of a single disulfide bond attenuates the activity observed for HD5(ox) against this Gram-positive bacterial strain. This observation supports the notion that the HD5(ox) mechanism of antibacterial action differs for Gram-negative and Gram-positive species [Wei et al. (2009) J. Biol. Chem. 284, 29180-29192] and that the native disulfide array is a requirement for its activity against S. aureus.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861459      PMCID: PMC3179267          DOI: 10.1021/bi201043j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  60 in total

1.  Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

Authors:  Tanja Schneider; Thomas Kruse; Reinhard Wimmer; Imke Wiedemann; Vera Sass; Ulrike Pag; Andrea Jansen; Allan K Nielsen; Per H Mygind; Dorotea S Raventós; Søren Neve; Birthe Ravn; Alexandre M J J Bonvin; Leonardo De Maria; Anders S Andersen; Lora K Gammelgaard; Hans-Georg Sahl; Hans-Henrik Kristensen
Journal:  Science       Date:  2010-05-28       Impact factor: 47.728

2.  Artificial beta-defensin based on a minimal defensin template.

Authors:  Nikolinka Antcheva; Francesca Morgera; Luisa Creatti; Lisa Vaccari; Ulrike Pag; Sabrina Pacor; Yechiel Shai; Hans-Georg Sahl; Alessandro Tossi
Journal:  Biochem J       Date:  2009-07-15       Impact factor: 3.857

3.  Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.

Authors:  Vera Sass; Tanja Schneider; Miriam Wilmes; Christian Körner; Alessandro Tossi; Natalia Novikova; Olga Shamova; Hans-Georg Sahl
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

4.  Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.

Authors:  Erik de Leeuw; Changqing Li; Pengyun Zeng; Chong Li; Marlies Diepeveen-de Buin; Wei-Yue Lu; Eefjan Breukink; Wuyuan Lu
Journal:  FEBS Lett       Date:  2010-03-07       Impact factor: 4.124

5.  The membrane-bound structure and topology of a human α-defensin indicate a dimer pore mechanism for membrane disruption.

Authors:  Yuan Zhang; Wuyuan Lu; Mei Hong
Journal:  Biochemistry       Date:  2010-10-26       Impact factor: 3.162

6.  Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.

Authors:  Paulina Schmitt; Miriam Wilmes; Martine Pugnière; André Aumelas; Evelyne Bachère; Hans-Georg Sahl; Tanja Schneider; Delphine Destoumieux-Garzón
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

7.  Expression and purification of recombinant alpha-defensins and alpha-defensin precursors in Escherichia coli.

Authors:  Sharel Figueredo; Jennifer R Mastroianni; Kenneth P Tai; André J Ouellette
Journal:  Methods Mol Biol       Date:  2010

8.  Through the looking glass, mechanistic insights from enantiomeric human defensins.

Authors:  Gang Wei; Erik de Leeuw; Marzena Pazgier; Weirong Yuan; Guozhang Zou; Jianfeng Wang; Bryan Ericksen; Wei-Yue Lu; Robert I Lehrer; Wuyuan Lu
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

9.  Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.

Authors:  Karthik Balakrishna Chandrababu; Bow Ho; Daiwen Yang
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

10.  Enteric defensins are essential regulators of intestinal microbial ecology.

Authors:  Nita H Salzman; Kuiechun Hung; Dipica Haribhai; Hiutung Chu; Jenny Karlsson-Sjöberg; Elad Amir; Paul Teggatz; Melissa Barman; Michael Hayward; Daniel Eastwood; Maaike Stoel; Yanjiao Zhou; Erica Sodergren; George M Weinstock; Charles L Bevins; Calvin B Williams; Nicolaas A Bos
Journal:  Nat Immunol       Date:  2009-10-22       Impact factor: 25.606

View more
  24 in total

1.  Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5.

Authors:  Haritha R Chileveru; Shion A Lim; Phoom Chairatana; Andrew J Wommack; I-Ling Chiang; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2015-03-02       Impact factor: 3.162

Review 2.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

3.  Conformational landscape and pathway of disulfide bond reduction of human alpha defensin.

Authors:  Joost Snijder; Michiel van de Waterbeemd; Matthew S Glover; Liuqing Shi; David E Clemmer; Albert J R Heck
Journal:  Protein Sci       Date:  2015-05-27       Impact factor: 6.725

4.  NMR solution structure and condition-dependent oligomerization of the antimicrobial peptide human defensin 5.

Authors:  Andrew J Wommack; Scott A Robson; Yoshitha A Wanniarachchi; Andrea Wan; Christopher J Turner; Gerhard Wagner; Elizabeth M Nolan
Journal:  Biochemistry       Date:  2012-11-19       Impact factor: 3.162

5.  Antimicrobial Peptides Share a Common Interaction Driven by Membrane Line Tension Reduction.

Authors:  J Michael Henderson; Alan J Waring; Frances Separovic; Ka Yee C Lee
Journal:  Biophys J       Date:  2016-11-15       Impact factor: 4.033

Review 6.  Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut.

Authors:  Phoom Chairatana; Elizabeth M Nolan
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-11-13       Impact factor: 8.250

7.  A bacterial mutant library as a tool to study the attack of a defensin peptide.

Authors:  Simone Moser; Haritha R Chileveru; Jill Tomaras; Elizabeth M Nolan
Journal:  Chembiochem       Date:  2014-11-27       Impact factor: 3.164

8.  A Requirement for Metamorphic Interconversion in the Antimicrobial Activity of Chemokine XCL1.

Authors:  Amanda M Nevins; Akshay Subramanian; Jazma L Tapia; David P Delgado; Robert C Tyler; Davin R Jensen; André J Ouellette; Brian F Volkman
Journal:  Biochemistry       Date:  2016-06-28       Impact factor: 3.162

Review 9.  Human α-Defensin 6: A Small Peptide That Self-Assembles and Protects the Host by Entangling Microbes.

Authors:  Phoom Chairatana; Elizabeth M Nolan
Journal:  Acc Chem Res       Date:  2017-03-15       Impact factor: 22.384

10.  A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Cheng Wang; Gaomei Zhao; Song Wang; Yin Chen; Yali Gong; Shilei Chen; Yang Xu; Mengjia Hu; Xinmiao Wang; Hao Zeng; Aiping Wang; Dengqun Liu; Yongping Su; Tianmin Cheng; Fang Chen; Junping Wang
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.